BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 14507273)

  • 1. Randomized placebo-controlled study of oral calcium carbonate supplementation in plateletpheresis: II. Metabolic effects.
    Bolan CD; Cecco SA; Yau YY; Wesley RA; Oblitas JM; Rehak NN; Leitman SF
    Transfusion; 2003 Oct; 43(10):1414-22. PubMed ID: 14507273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized placebo-controlled study of oral calcium carbonate administration in plateletpheresis: I. Associations with donor symptoms.
    Bolan CD; Wesley RA; Yau YY; Cecco SA; Starling J; Oblitas JM; Rehak NN; Leitman SF
    Transfusion; 2003 Oct; 43(10):1403-13. PubMed ID: 14507272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium supplementation attenuates citrate-related changes in bone metabolism: a placebo-controlled crossover study in healthy volunteers.
    Chen Y; Hou J; Chen G; Lin H; Lin H; Chu X; Zeng J; Chen C; Lin J; Dettke M
    Bone; 2011 Sep; 49(3):506-12. PubMed ID: 21635981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of citrate effects during plateletpheresis in normal donors.
    Bolan CD; Greer SE; Cecco SA; Oblitas JM; Rehak NN; Leitman SF
    Transfusion; 2001 Sep; 41(9):1165-71. PubMed ID: 11552076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone Turnover Markers Changes Induced by Plateletpheresis May Be Minimized with Oral Supplementation of Calcium, Minerals, and Vitamin D before the Procedures: A Non-Randomized, Controlled Study.
    Barrientos-Galeana E; Tolentino-Dolores MC; Morales-Hernández RM; Sámano R; Chico-Barba G; Fernández-Sánchez E; Zamora-Sánchez LJ; Alonso-López AD; López-Martínez H; Alba-Rosales T; Sánchez-Guerrero SA
    J Clin Med; 2022 Dec; 12(1):. PubMed ID: 36615081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium and magnesium levels during automated plateletpheresis in normal donors.
    Das SS; Chaudhary R; Khetan D; Shukla JS; Agarwal P; Mishra RB
    Transfus Med; 2005 Jun; 15(3):233-6. PubMed ID: 15943708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypocalcemic symptoms during plateletpheresis using the COBE Spectra: a comparison of oral combination of 600mg calcium+300mg magnesium+100IU vitamin D3 vs. a 1000mg calcium in symptomatic donors.
    Palfi M; Martinsson L; Sundström K
    Transfus Apher Sci; 2007 Jun; 36(3):291-5. PubMed ID: 17613274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of ionized magnesium measurement for monitoring of citrate-anticoagulated plateletpheresis.
    Mercan D; Bastin G; Lambermont M; Dupont E
    Transfusion; 1997 Apr; 37(4):418-22. PubMed ID: 9111280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placebo-controlled study of intravenous magnesium supplementation during large-volume leukapheresis in healthy allogeneic donors.
    Haddad S; Leitman SF; Wesley RA; Cecco S; Yau YY; Starling J; Rehak NN; Bolan CD
    Transfusion; 2005 Jun; 45(6):934-44. PubMed ID: 15934992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and clinicopathologic effects of plateletpheresis on healthy donor dogs.
    Callan MB; Appleman EH; Shofer FS; Mason NJ; Brainard BM; Groman RP
    Transfusion; 2008 Oct; 48(10):2214-21. PubMed ID: 18564392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration in biochemical parameters during plateletpheresis in healthy donors: A compendious analysis.
    Garg K; Kaur P; Bedi RK; Gupta S
    Transfus Clin Biol; 2021 Aug; 28(3):239-245. PubMed ID: 33965622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled study of citrate effects and response to i.v. calcium administration during allogeneic peripheral blood progenitor cell donation.
    Bolan CD; Cecco SA; Wesley RA; Horne M; Yau YY; Remaley AT; Childs RW; Barrett AJ; Rehak NN; Leitman SF
    Transfusion; 2002 Jul; 42(7):935-46. PubMed ID: 12375668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic administration of oral calcium carbonate during plateletpheresis: A bicentric prospective study.
    Pandey PK; Tiwari A; Agarwal N; Dara RC
    Asian J Transfus Sci; 2020; 14(1):19-22. PubMed ID: 33162700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of phosphorus-containing calcium preparation (bone meal powder) and calcium carbonate on serum calcium and phosphorus in young and old healthy volunteers: a double-blinded crossover study.
    Tsuboi M; Shiraki M; Hamada M; Shimodaira H
    J Bone Miner Metab; 2000; 18(6):321-7. PubMed ID: 11052464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of continuous infusion of citrate on responses of immunoreactive parathyroid hormone, calcium and magnesium components, and other electrolytes in normal adults during plateletapheresis.
    Toffaletti J; Nissenson R; Endres D; McGarry E; Mogollon G
    J Clin Endocrinol Metab; 1985 May; 60(5):874-9. PubMed ID: 3980672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daily oral magnesium supplementation suppresses bone turnover in young adult males.
    Dimai HP; Porta S; Wirnsberger G; Lindschinger M; Pamperl I; Dobnig H; Wilders-Truschnig M; Lau KH
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2742-8. PubMed ID: 9709941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Short-term effects of citrate on markers of bone metabolism in Chinese blood donor volunteers].
    Chu XL; Hou JM; Lin H; Lin HK; Zeng J; Chen GL; Chen C; Lin J; Chen Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):785-9. PubMed ID: 20561451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Play of Citrate Infusion with Calcium in Plateletpheresis Donors.
    Lokhande T; Thomas S; Kumar G; Bajpai M
    Indian J Hematol Blood Transfus; 2021 Apr; 37(2):295-301. PubMed ID: 33867737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of oral calcitriol pulse therapy on the lipid, calcium, and glucose homeostasis of hemodialysis-patients: its safety in a combination with oral calcium carbonate.
    Khajehdehi P; Taheri S
    J Ren Nutr; 2003 Apr; 13(2):78-83. PubMed ID: 12671829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.